Abstract:Piperlongumine (PL) has multiple anticancer effects by targeting different pathways associated with cancer. Pharmaceutical researchers have been trying to optimise the structure of PL‐derivatives to improve their drug‐likeness profiles. Drug chemistry analyses of a large number of PL‐derivatives revealed that most of them showed higher anticancer potency and drug‐ability than the native PL. Piperlongumine, or piplartine (PL), is a bioactive alkaloid isolated from Piper longum L. and a potent phytoconstituent in Indian Ayurveda and traditional Chinese medicine with a lot of therapeutic benefits. Apart from all of its biological activities, it demonstrates multimodal anticancer activity by targeting various cancer‐associated pathways and being less toxic to normal cells. According to their structure–activity relationship (SAR), the trimethylphenyl ring (cinnamoyl core) and 5,6‐dihydropyridin‐2‐(1H)‐one (piperdine core) are responsible for the potent anticancer activity. However, it has poor intrinsic properties (low aqueous solubility, poor bioavailability, etc.). As a result, pharmaceutical researchers have been trying to optimise or modify the structure of PL to improve the drug‐likeness profiles. The present review selected 26 eligible research articles on PL derivatives published between 2012 and 2023, followed by the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) format. We have thoroughly summarised the anticancer potency, mode of action, SAR and drug chemistry of the proposed PL‐derivatives against different cancer cells. Overall, SAR analyses with respect to anticancer potency and drug‐ability revealed that substitution of methoxy to hydroxyl, attachment of ligustrazine and 4‐hydroxycoumarin heterocyclic rings in place of phenyl rings, and attachment of heterocyclic rings like indole at the C7‐C8 olefin position in native PL can help to improve anticancer activity, aqueous solubility, cell permeability, and bioavailability, making them potential leads. Hopefully, the large‐scale collection and critical drug‐chemistry analyses will be helpful to pharmaceutical and academic researchers in developing potential, less‐toxic and cost‐effective PL‐derivatives that can be used against different cancers.

The phytochemical plumbagin: mechanism behind its "pleiotropic" nature and potential as an anticancer treatment

Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review

Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances

Copper-Plumbagin Complex Produces Potent Anticancer Effects by Depolymerizing Microtubules and Inducing Reactive Oxygen Species and DNA Damage

Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical Translation

Lead Phytochemicals for Anticancer Drug Development

Biosynthesis of anticancer phytochemical compounds and their chemistry

Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice

Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspective

Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment

Piperlongumine and its derivatives against cancer: A recent update and future prospective

Paclitaxel and its semi-synthetic derivatives: comprehensive insights into chemical structure, mechanisms of action, and anticancer properties

Plumbagin, a Natural Product with Potent Anticancer Activities, Binds to and Inhibits Dihydroorotase, a Key Enzyme in Pyrimidine Biosynthesis

A Review on Mechanistic Insight of Plant Derived Anticancer Bioactive Phytocompounds and Their Structure Activity Relationship

Nature's weapons: Bioactive compounds as anti-cancer agents

Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics

Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin

Plant-based natural products in cancer therapeutics

In-vitro Studies of Extracts of Plumbago Zeylanica in Cancer Cell Lines

Cure lies in nature: medicinal plants and endophytic fungi in curbing cancer

Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights